Teva Pharmaceutical Industries Limited Overview
Pro stress-test →Teva Pharmaceutical Industries develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. As a global pharmaceutical leader, Teva serves markets across multiple continents with a diverse portfolio spanning generic drugs, specialty pharmaceuticals, and over-the-counter products.
Strategic Profile
Pro stress-test →The company offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms. Teva combines scale in generics with branded specialty pharmaceuticals including COPAXONE for multiple sclerosis, AJOVY for migraine prevention, and AUSTEDO for movement disorders.
Competitive Landscape
Pro stress-test →Teva competes with major pharmaceutical companies including AbbVie, Pfizer, Dr. Reddy's, Roche, and other generic and specialty pharma players. The company maintains competitive advantage through its diversified portfolio spanning both high-volume generics and specialty medications, balanced by geographic diversification and strategic partnerships.
Industry Context
Teva Pharmaceutical Industries Limited operates in Pharmaceuticals - Generic & Specialty.
Key facts
Founded: 1901 · Headquarters: Petah Tikva, Israel · Revenue: $17.3B · Market cap: $39-41B